Does BOCEPREVIR Cause Hepatocellular carcinoma? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hepatocellular carcinoma have been filed in association with BOCEPREVIR. This represents 0.9% of all adverse event reports for BOCEPREVIR.
19
Reports of Hepatocellular carcinoma with BOCEPREVIR
0.9%
of all BOCEPREVIR reports
6
Deaths
8
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From BOCEPREVIR?
Of the 19 reports, 6 (31.6%) resulted in death, 8 (42.1%) required hospitalization.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOCEPREVIR. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does BOCEPREVIR Cause?
Anaemia (555)
Fatigue (316)
Nausea (283)
Neutropenia (201)
Rash (177)
Headache (158)
Thrombocytopenia (154)
Vomiting (153)
Dysgeusia (148)
Diarrhoea (137)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which BOCEPREVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
BOCEPREVIR vs BOCOCIZUMAB
BOCEPREVIR vs BONIVA
BOCEPREVIR vs BONVIVA
BOCEPREVIR vs BORAGE OIL
BOCEPREVIR vs BORIC ACID